Abstract
In order to improve the lipophilicity of peptides, bovine insulin was chosen for the chemical modification using palmitic acid. The N-hydroxysuccinimide ester of palmitic acid was used for attachment to terminal amino groups, and p-methoxybenzoxycarbonyl azide was used for protection of the glycine-Al amino terminus. We obtained two purified derivatives of insulin, Bl-monopalmitoyl- and Bl,B29-dipalmitoyl-insulin, which were confirmed to be more lipophilic than the parent insulin on high-performance liquid chromatography (HPLC). The hypoglycemic effects of both products were measured in rats after intravenous and intramuscular injections. The mono derivative was more active than the di derivative and produced a longer effect duration than the native insulin after intravenous injection. The derivatives were also shown to be less immunoreactive as judged by an enzyme immunoassay.
Similar content being viewed by others
REFERENCES
S. S. Davis. In S. S. Davis, L. Illum, and E. Tomlinson (eds.), Delivery Systems for Peptide Drugs, Plenum Press, New York, 1986, pp. 1–21.
D. G. Lindsay and S. Shall. Biochem. J. 115:587–595 (1969).
D. G. Lindsay and S. Shall. Biochem. J. 121:737–745 (1971).
H. Zahn, D. Brandenburg, and H. Gottner. Diabetes 21:468–475 (1972).
K. Hoffman, F. M. Finn, H. Friesen, C. Diaconeseu, and H. Zahn. Proc. Natl. Acad. Sci. 74: 2697–2700 (1977).
G. A. J. Van Os, E. J. Ariens, and A. M. Simonis. In, E. J. Ariens (ed.), Molecular Pharmacology I, Academic Press, New York, 1964, pp. 7–48.
Y. Lapidot, S. Rapporort, and Y. Wolman. J. Lipid Res. 8:142–145 (1967).
P. Sharp. Clin. Chim. Acta 40:115–120 (1972).
W. A. Ritschel and G. B. Ritschel. In B. Glas and C. J. deBlaey (eds.), Rectal Therapy, J. R. Prous, Spain, 1984, pp. 67–83.
H. Shinkai, M. Sohma, Y. Takahashi, R. Kojima, M. Hashimoto, and N. Ogawa. Mol. Immunol. 17:377–381 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hashimoto, M., Takada, K., Kiso, Y. et al. Synthesis of Palmitoyl Derivatives of Insulin and Their Biological Activities. Pharm Res 6, 171–176 (1989). https://doi.org/10.1023/A:1015992828666
Issue Date:
DOI: https://doi.org/10.1023/A:1015992828666